Dementia Clinical Trials

A listing of Dementia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35294

A clinical trial to evaluate treatments using SYN120 and Placebo for patients with Parkinson's Disease Dementia (PDD)

Tuscaloosa Alabama 35404

Patients are needed to participate in a clinical research study evaluating Brexpiprazole, OPC-34712 for the treatment of Dementia

Arizona

Xenoscience
Phoenix Arizona 85004

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

View More ▼

UPDATED

Phoenix Arizona 85004

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

Scottsdale Arizona 85260

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

Scottsdale Arizona 85258

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

Tucson Arizona 85718

A Phase 3 clinical study for patients with Alzheimer's Disease

Phoenix Arizona 85032

A clinical research study of AVP-786 and Placebo for the treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Phoenix Arizona 85013

A Phase 2 clinical study for patients with Dementia With Lewy Bodies, The HEADWAY-DLB Study

Phoenix Arizona 85013

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

Phoenix Arizona 85006

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

Phoenix Arizona

Patients are needed to participate in a clinical research study evaluating AVP-786 for the treatment of Agitation in Alzheimer's Disease

Phoenix Arizona 85006

Patients are needed to participate in a clinical research study of AVP-786 and Placebo to evaluate Agitation in Patients With Dementia of the Alzheimer's Type

Sun City Arizona 85351

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

Tucson Arizona 85704

A Phase 2 clinical study for patients with Dementia With Lewy Bodies, The HEADWAY-DLB Study

Tucson Arizona 85704

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

Arkansas

Fayetteville Arkansas

Patients are needed to participate in a clinical research study evaluating AVP-786 for the treatment of Agitation in Alzheimer's Disease

Fayetteville Arkansas 72703

Patients are needed to participate in a clinical research study of AVP-786 and Placebo to evaluate Agitation in Patients With Dementia of the Alzheimer's Type

California

Alliance Research Center
Laguna Hills California 92653

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Renew Behavioral Health, Inc.
Long Beach California 90807

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Pharmacology Research Institute, Newport Beach
Newport Beach California 92660

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 26-Week, Phase 3 Study of Two Doses of EVP-6125 or Placebo in Subjects with Mild to Moderate Alzheimer's Disease Currently or Previously Receiving an Acetylcholinesterase Inhibitor Medication

Excell Research, Inc.
Oceanside California 92056

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Asclepes Research Center
Panorama City California 91402

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Northern California Research
Sacramento California 95821

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Northern California Research
Sacramento California 95821

Patients with Mild-Moderate Alzheimer's Disease

Sharp Mesa Vista Hospital Clinical Research Center
San Diego California 92123

This study is a Placebo-controlled, Double-blind, Parallel-group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease.

San Francisco Clinical Research Center
San Francisco California 94530

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Schuster Medical Research Institute
Sherman Oaks California 91403

A Phase III, Randomized, Placebo-Controlled, Double Blind Clinical Trial to study the Efficacy and Safety of MK-8931 in Subjects with Amnestic Mild Cognitive Impairment (aMCI) due to Alzheimer’s Disease (prodromal AD).

View More ▼

UPDATED

Anaheim California 92805

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

Carlsbad California 92011

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

Fresno California 93710

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

Fullerton California 92835

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

San Diego California 92103

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

San Diego California 92103-6204

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

Santa Ana California 92705

A Phase 2 clinical study for patients with Alzheimer's Disease

UPDATED

Santa Ana California 92705

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

Sherman Oaks California 91403

A Phase 3 clinical study for patients with Alzheimer's Disease

Bellflower California

Patients are needed to participate in a clinical research study evaluating E2609 and Placebo for the treatment of Alzheimer Disease or Dementia, Alzheimer Type

Costa Mesa California 92627

Patients are needed to participate in a clinical research study evaluating Brexpiprazole, OPC-34712 for the treatment of Dementia

Costa Mesa California

Patients are needed to participate in a clinical research study evaluating E2609 and Placebo for the treatment of Alzheimer Disease or Dementia, Alzheimer Type

Fountain Valley California 92708

A Phase 2 clinical study for patients with Lewy Body Dementia or Visual Hallucinations

Fremont California 94538

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

Glendale California

Patients are needed to participate in a clinical research study evaluating AVP-786 for the treatment of Agitation in Alzheimer's Disease

Glendale California

Patients are needed to participate in a clinical research study evaluating E2609 and Placebo for the treatment of Alzheimer Disease or Dementia, Alzheimer Type

Glendale California 91206

Patients are needed to participate in a clinical research study of AVP-786 and Placebo to evaluate Agitation in Patients With Dementia of the Alzheimer's Type

Glendale California

Patients are needed to participate in a clinical research study of E2027 and E2027 matched placebo to evaluate Lewy Body Dementias (LBD), Parkinson's Disease Dementia (PDD) or Dementia With Lewy Bodies (DLB)

Irvine California 92868

Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease

Irvine California

Patients are needed to participate in a clinical research study evaluating E2609 and Placebo for the treatment of Alzheimer Disease or Dementia, Alzheimer Type

La Habra California 90631

Patients are needed to participate in a clinical research study of AVP-786 and Placebo to evaluate Agitation in Patients With Dementia of the Alzheimer's Type

La Jolla California 92037

A clinical trial to evaluate treatments using SYN120 and Placebo for patients with Parkinson's Disease Dementia (PDD)